Keywords: amylin/lilly, byetta, comparable, insulin, drugmakers, amylin, pharmaceuticals

Amylin/Lilly's Byetta comparable to insulin

Article | 07 February 2007

Print This

US drugmakers Amylin Pharmaceuticals and Eli Lilly say that the results of a study that compared their co-developed antidiabetic Byetta ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in